melatonin has been researched along with thromboxanes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunnane, SC; Horrobin, DF; Manku, MS | 1 |
| Ally, AI; Cunnane, SC; Ghayur, T; Horrobin, DF; Karmali, RA; Karmazyn, M; Manku, MS; Morgan, RO; Oka, M | 1 |
| Horrobin, DF | 1 |
| Leach, CM; Thorburn, GD | 1 |
| Lippert, TH; Mueck, AO; Seeger, H | 1 |
5 other study(ies) available for melatonin and thromboxanes
| Article | Year |
|---|---|
The pineal and regulation of fibrosis: pinealectomy as a model of primary biliary cirrhosis: roles of melatonin and prostaglandins in fibrosis and regulation of T lymphocytes.
Topics: Animals; Colchicine; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Melatonin; Models, Biological; Penicillamine; Pineal Gland; Prostaglandins E; Schizophrenia; T-Lymphocytes; Thromboxane A2; Thromboxanes; Zinc | 1979 |
Influence of agents which modulate thromboxane A2 synthesis or action on R3230AC mammary carcinoma.
Topics: Animals; Colchicine; Copper; Diazepam; Dipyridamole; Female; Mammary Neoplasms, Experimental; Melatonin; Rats; Thromboxane A2; Thromboxanes | 1978 |
A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2.
Topics: Cardiovascular Diseases; Cholesterol; Collagen; Fatty Acids, Essential; Feedback; Humans; Insulin; Life Style; Melatonin; Models, Biological; Platelet Aggregation; Prostaglandins E; Thromboxane A2; Thromboxanes; Vasoconstriction | 1980 |
A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release.
Topics: Arachidonic Acids; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Humans; Indomethacin; Melatonin; Platelet Aggregation; Thromboxanes | 1980 |
[Effect of transdermal versus oral estradiol administration on the excretion of vasoactive markers in postmenopausal women].
Topics: Administration, Cutaneous; Administration, Oral; Aged; Cyclic GMP; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Hormones; Humans; Inflammation Mediators; Insulin; Melatonin; Middle Aged; Postmenopause; Relaxin; Serotonin; Thromboxanes; Time Factors; Vasodilation | 2000 |